These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 28889782)
61. Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck. Bauernhofer T; Pichler M; Wieckowski E; Stanson J; Aigelsreiter A; Griesbacher A; Groselj-Strele A; Linecker A; Samonigg H; Langner C; Whiteside TL Br J Cancer; 2011 May; 104(10):1641-8. PubMed ID: 21505459 [TBL] [Abstract][Full Text] [Related]
62. ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma. Shen Z; Hu Y; Zhou C; Yuan J; Xu J; Hao W; Deng H; Ye D J Clin Lab Anal; 2019 Jul; 33(6):e22899. PubMed ID: 31002184 [TBL] [Abstract][Full Text] [Related]
63. Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers. Goulioumis AK; Fuxe J; Varakis J; Repanti M; Goumas P; Papadaki H Oncol Rep; 2009 Nov; 22(5):1063-8. PubMed ID: 19787222 [TBL] [Abstract][Full Text] [Related]
64. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants. Marioni G; Agostini M; Bedin C; Blandamura S; Stellini E; Favero G; Lionello M; Giacomelli L; Burti S; D'Angelo E; Nitti D; Staffieri A; De Filippis C Histopathology; 2012 Aug; 61(2):247-56. PubMed ID: 22416874 [TBL] [Abstract][Full Text] [Related]
65. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival. Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379 [TBL] [Abstract][Full Text] [Related]
66. [Expressions and clinical significance of high mobility group box-1 mRNA and protein in laryngeal squamous cell carcinoma tissues and serum]. Guo Y; Liu Y; Tan PQ; Li G; Su ZW; Tian YQ; Qiu YZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):487-90. PubMed ID: 22932142 [TBL] [Abstract][Full Text] [Related]
68. Protein marker profiling in different T classification in laryngeal squamous cell carcinoma. Chen W; Ye F; Cui M; Sikora AG; Wang X; Wang P; Cui X; Guo X; Zhu W; Zhang DY Head Neck; 2015 Mar; 37(3):357-65. PubMed ID: 24753215 [TBL] [Abstract][Full Text] [Related]
69. [DJ-1 expression in laryngeal squamous cell carcinoma and its relationship with tumor recurrence and metastasis]. Zhu XL; Wen WP; Lei WB; Chai LP; Hou WJ; Wen YH; Wang XR Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun; 45(6):497-501. PubMed ID: 21055329 [TBL] [Abstract][Full Text] [Related]
70. Overexpression of interleukin-l7 in tumor-associated macrophages is correlated with the differentiation and angiogenesis of laryngeal squamous cell carcinoma. Meng CD; Zhu DD; Jiang XD; Li L; Sha JC; Dong Z; Kong H Chin Med J (Engl); 2012 May; 125(9):1603-7. PubMed ID: 22800829 [TBL] [Abstract][Full Text] [Related]
71. [The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance]. Chen Y; He Y; Zhang S; Li L; Zhu X; Liu Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 23(12):539-41, 545. PubMed ID: 19771908 [TBL] [Abstract][Full Text] [Related]
72. LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma. Qiu X; You Y; Huang J; Wang X; Zhu H; Wang Z Int J Clin Exp Pathol; 2015; 8(5):5519-27. PubMed ID: 26191259 [TBL] [Abstract][Full Text] [Related]
73. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma. Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924 [TBL] [Abstract][Full Text] [Related]
74. The prognostic value of sex hormone receptors expression in laryngeal carcinoma. Atef A; El-Rashidy MA; Elzayat S; Kabel AM Tissue Cell; 2019 Apr; 57():84-89. PubMed ID: 30947969 [TBL] [Abstract][Full Text] [Related]
76. Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder. Erben P; Sikic D; Wirtz RM; Martini T; Weis CA; Breyer J; Otto W; Keck B; Hartmann A; Bolenz C; Virchows Arch; 2019 Feb; 474(2):209-217. PubMed ID: 30483954 [TBL] [Abstract][Full Text] [Related]
77. Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor. Kuasne H; Barros-Filho MC; Marchi FA; Drigo SA; Scapulatempo-Neto C; Faria EF; Rogatto SR Virchows Arch; 2018 Nov; 473(5):607-614. PubMed ID: 30099587 [TBL] [Abstract][Full Text] [Related]
78. Prognostic implication of CEACAM1 expression in squamous cell carcinoma of the larynx: Pilot study. Lucarini G; Zizzi A; Re M; Sayeed MA; Di Primio R; Rubini C Head Neck; 2019 Jun; 41(6):1615-1621. PubMed ID: 30582236 [TBL] [Abstract][Full Text] [Related]
79. High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma. Han L; Jiang B; Wu H; Wang X; Tang X; Huang J; Zhu J Med Oncol; 2012 Dec; 29(4):2466-72. PubMed ID: 22274915 [TBL] [Abstract][Full Text] [Related]
80. Analysis of sex-hormone-receptor expression in laryngeal carcinoma. Hagedorn HG; Nerlich AG Eur Arch Otorhinolaryngol; 2002 Apr; 259(4):205-10. PubMed ID: 12064509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]